基本信息
浏览量:449
职业迁徙
个人简介
Dr Gleave established a role for clusterin as a cancer-related cell survival protein involved in treatment resistance and developed an inhibitor, designated OGX-011, which improved the efficacy of hormone- and chemo-therapies in prostate and other cancer models. He is the scientific founder of OncoGenex Pharmaceuticals Inc. and a Member of the Order of Canada.
研究兴趣
论文共 1442 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Scientific Reportsno. 1 (2024): 1-12
COMMUNICATIONS BIOLOGYno. 1 (2024)
Stephen J. Freedland,Ugo De Giorgi,Martin Gleave,Jamal Tarazi,Yiyun Tang,Gabriel P. Haas, Matt Rosales,Fabian Zohren,Neal D. Shore
Communications Biologyno. 1 (2024): 108-108
Shiqin Liu,Sarah Hawley,Christian Kunder,En-Chi Hsu,Michelle Shen,Merve Aslan, Fernando J. Marques, Chung S. Lee,Abel Bermudez, Lennart Westphalen,Heidi Auman,Lisa F. Newcomb,
Cancer Researchno. 6_Supplement (2024): 6962-6962
JU open plusno. 4 (2024)
Yu Wang,Hui Xue, Xiaohui Zhu,Dong Lin,Xin Dong,Zheng Chen,Junru Chen,Mingchen Shi,Yuchao Ni, Jonathan Cao,Rebecca Wu, Ning Kang,
bioRxiv : the preprint server for biology (2024)
Medical Image Analysis (2024): 103197-103197
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn